1. Bioworld Biopharma products in development for COVID-19 (2020); www.bioworld.com/COVID19products.
2. J. Corum S. L. Wee C. Zimmer Coronavirus vaccine tracker (2020); www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html.
3. FDA, “Development and licensure of vaccines to prevent COVID-19: Guidance for industry” (FDA-2020-D-1137, FDA, 2020); www.fda.gov/media/139638/download.
4. Pfizer “Pfizer and BioNTech announce vaccine candidate against COVID-19 achieved success in first interim analysis from phase 3 study ” 9 November 2020; www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-vaccine-candidate-against.
5. Moderna “Moderna's COVID-19 vaccine candidate meets its primary efficacy endpoint in the first interim analysis of the phase 3 COVE study ” 16 November 2020; https://investors.modernatx.com/news-releases/news-release-details/modernas-covid-19-vaccine-candidate-meets-its-primary-efficacy.